Cereset Research Exploratory Study
Launched by WAKE FOREST UNIVERSITY HEALTH SCIENCES · Dec 14, 2018
Trial Information
Current as of July 09, 2025
Recruiting
Keywords
ClinConnect Summary
The Cereset Research Exploratory Study is looking into a new approach to help people who are dealing with stress, anxiety, or insomnia. The goal of this study is to see if a technique called Cereset Research can improve how the body's autonomic system functions, which plays a key role in managing stress and relaxation. The study is currently recruiting participants aged 18 and older, and it is open to all genders.
To be eligible for the study, participants need to be experiencing symptoms of stress, anxiety, or insomnia and should be able to follow simple instructions while comfortably sitting still for about 1.5 hours. If you or someone you know is interested, it's important to note that there are some exclusions, such as being unable to consent, having severe hearing issues, or being currently involved in another research study. Participants can expect to be part of a supportive environment where they will receive guidance and assistance throughout the process, while contributing to valuable research that may help improve mental well-being for others in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Subjects must have the ability to comply with basic instructions and be able to sit still comfortably with the sensor leads attached
- • Subjects experiencing symptoms of stress, anxiety, or insomnia, who meet threshold scores on one or more self-reported inventories for the same. This includes the Insomnia Severity Index (ISI, ≥ 8), the Perceived Stress Index (PSS, ≥ 14), or the Generalized Anxiety Disorder 7-item (GAD-7, ≥ 5) scale.
- Exclusion Criteria:
- • Unable, unwilling, or incompetent to provide informed consent/assent.
- • Physically unable to come to the study visits, or to sit comfortably in a chair for up to 1.5 hours.
- • Severe hearing impairment (because the subject will be using ear buds during CR).
- • Anticipated and ongoing use of alcohol or recreational drugs.
- • Weight is over the chair limit (285 pounds).
- • Currently in another active intervention research study.
- • Prior use of HIRREM, Brainwave Optimization, Cereset, or a wearable configuration of the same (B2, or B2v2).
- • Prior use of electroconvulsive therapy (ECT).
- • Prior use of transcranial magnetic stimulation (TMS), transcranial direct current stimulation (TDCS), alpha stimulation, neurofeedback, biofeedback, or deep brain stimulation (DBS) within one month before enrollment.
- • Known seizure disorder.
About Wake Forest University Health Sciences
Wake Forest University Health Sciences is a leading academic research institution dedicated to advancing healthcare through innovative clinical trials and translational research. With a strong emphasis on multidisciplinary collaboration, the organization leverages its extensive expertise in medical research, patient care, and education to develop and evaluate new therapies and interventions. Committed to improving patient outcomes and public health, Wake Forest University Health Sciences fosters a dynamic environment for scientific inquiry, engaging in a wide range of clinical studies that address pressing health challenges. Through its rigorous methodologies and ethical standards, the institution aims to contribute significantly to the medical field and enhance the quality of life for diverse populations.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Winston Salem, North Carolina, United States
Patients applied
Trial Officials
Charles Tegeler, MD
Principal Investigator
Wake Forest University Health Sciences
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials